ERBB2 and breast carcinoma: For example, C-X-C Motif Chemokine Ligand 8 (CXCL8), reported to promote breast cancer progression47, in our analysis was significantly decreased (3-fold-change) among AA patients compared with W patients of Her2 subtype, MBNL2 (member of the OSR pathway), TMC6 (member of the immune pathway/Table 1), PCDH7 (member of the XIAP pathway), and ACSM3 (member of the XIAP pathway) to be of significance in AA-Basal subtype patients.